Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Artivion Inc.

Clinical trials sponsored by Artivion Inc., explained in plain language.

Artivion Inc. AORT NYSE

Medical device company focused on cardiac and vascular surgery products.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet recruiting 1

New device aims to improve survival in aortic arch surgery

Disease control Recruiting now

This study tests a new device called the Arcevo LSA Hybrid Stent Graft, used during open surgery to repair the aortic arch in people with aneurysms or dissections. The device is implanted to support the aorta and its left subclavian artery branch. Researchers will track safety an…

Phase: NA • Sponsor: Artivion Inc. • Aim: Disease control

Last updated Jul 12, 2026 00:00 UTC